Table 2.
Human papilloma virus vaccination and completion rates in patients between the ages of 9 and 14, stratified by race
| Race | Total eligiblea | HPV vaccineb at least once | Patients vaccinated once who completed series within 12 mo |
|---|---|---|---|
| White | 431,393 | 109,422 (25.4%) | 62,918 (57.5%) |
| Black or African American | 93,290 | 37,784 (40.5%) | 15,302 (40.5%) |
| Asian | 14,075 | 4,705 (33.4%) | 2,521 (53.6%) |
| American Indian | 3,063 | 898 (29.3%) | 518 (57.7%) |
| Native Hawaiian | 1,515 | 421 (27.9%) | 230 (54.6%) |
Abbreviation: HPV, Human papilloma virus.
a
Eligibility was defined as any patient with a documented racial identity having at least one outpatient encounter between the ages of 9 and 14, between January 1, 2014 and December 31, 2019.
b
Vaccination included bivalent HPV vaccination (CVX 118), quadrivalent HPV vaccination (CVX 62), 9-valent HPV vaccination (CVX 165), and “unspecified” HPV (CVX 137) vaccination.